论文期刊

取消

高级检索

检索历史清除

首页> Clinical infectious diseases : an official publication of the Infectious Diseases Society of America> The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States-Is There a Potential Role for Durlobactam?

The Growing Threat of NDM-Producing Escherichia coli With Penicillin-Binding Protein 3 Mutations in the United States-Is There a Potential Role for Durlobactam?

导出 LinkOut

翻译打印收藏纠错

作者： Samuel L,Aitken ^[1] ; Virginia M,Pierce ^[2] ; Jason M,Pogue ^[1] ; Ellen G,Kline ^[3] ; Frank P,Tverdek ^[4] ; Ryan K,Shields ^[3]

作者单位： Department of Pharmacy, Michigan Medicine, Ann Arbor, Michigan, USA.;Department of Clinical Pharmacy, University of Michigan College of Pharmacy, Ann Arbor, Michigan, USA. ^[1] Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA.;Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan, USA. ^[2] Division of Infectious Diseases, University of Pittsburgh Medical School, Pittsburgh, Pennsylvania, USA. ^[3] Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, Washington, USA.;Department of Pharmacy, School of Pharmacy, University of Washington, Seattle, Washington, USA. ^[4]

关键词 CMY New Delhi metallo beta-lactamase aztreonam cefiderocol zidebactam

主题词人类(Humans);大肠杆菌(Escherichia coli);β-内酰胺酶类(beta-Lactamases);微生物敏感性试验(Microbial Sensitivity Tests);抗菌药(Anti-Bacterial Agents);大肠杆菌感染(Escherichia coli Infections);青霉素结合蛋白质类(Penicillin-Binding Proteins);突变(Mutation);美国(United States);氮杂双环化合物(Azabicyclo Compounds);男(雄)性(Male);女(雌)性(Female);中年人(Middle Aged);氨曲南(Aztreonam);头孢菌素类(Cephalosporins);复方合剂(Drug Combinations);老年人(Aged);大肠杆菌蛋白质类(Escherichia coli Proteins)

DOI 10.1093/cid/ciae229

PMID 38661186

发布时间 2024-11-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Clinical infectious diseases

2024年79卷4期

834-837页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷